Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. - Wikidata - wikimedia - TriplyDB

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

http://www.wikidata.org/entity/Q34409573

about

Peripheral cannabinoid receptor, CB2, regulates bone mass.Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities Marijuana use and long-term mortality among survivors of acute myocardial infarction Is lipid signaling through cannabinoid 2 receptors part of a protective system?Cannabinoids in health and disease Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain CB2 receptor-mediated migration of immune cells: it can go either way The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin Beta-caryophyllene is a dietary cannabinoid AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation The endocannabinoid system as an emerging target of pharmacotherapy The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers Anticancer mechanisms of cannabinoids Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal The CB2 receptor and its role as a regulator of inflammation Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal study Endocannabinoids, blood pressure and the human heart.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2 Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.Targeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors.Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.Carboxylesterases: Dual roles in lipid and pesticide metabolism.Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.Rimonabant is a dual inhibitor of acyl CoA:cholesterol acyltransferases 1 and 2.CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state.

P2860

Erratum: Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

P921

Q24536360-A624D16D-4928-4931-9A61-01D056338A1B Q24623282-24A3D20C-A397-4F3E-9125-8B01819AA5B7 Q24629571-172D10DA-66C0-4080-B51D-9D81F02FC9D1 Q24633122-C9B97190-ED2C-4EC1-95C6-51A30766DB1D Q24633884-8166EF1D-65F1-46FF-BCE7-5FA600229C81 Q24634125-DBFEFABB-FBA5-4971-8454-900D9395D0BA Q24634161-4F62C3A0-7412-4CD8-9520-C1C026D92D59 Q24643591-FC94F371-ABC6-48D9-9170-58D4879026EF Q24643876-2F34F7A5-17B4-46D7-843E-A204D2FAD1AC Q24645478-78E52F90-2ECB-4A36-A6D9-06F683735D71 Q24647198-09C982A4-31C2-4C7B-9C4C-1FE884E2DCC8 Q24647850-F3EEAFA7-2C1C-4C54-A5F9-3D2E73EB3FE1 Q24648473-BAE78967-34BF-47C3-8F34-A1C4956D27CE Q24648765-A6E6FCB1-D706-4C2C-BB21-EA216E0D7C00 Q24650098-29ADF991-7A70-418A-A1D6-A51B90262544 Q24651712-97A43FF5-A345-4835-B3A8-7A94775B545A Q24654730-E260585F-FC53-473C-85BA-003B4D14D4F6 Q24673335-16218415-C1E8-433B-957D-61E47B2D9ADC Q26750399-61D2B00A-91E4-400A-9449-29D59CC02139 Q27000762-A2CD8453-8651-4D97-B3E6-DB8611E2F83B Q28066700-4DED19E4-CB31-4811-B094-626538C7A3FB Q28302804-FCAB81D4-475C-47FD-8D7C-0635997E2B41 Q28395270-CE4DAACB-2B9B-470B-AE3A-5CBB61767376 Q30368944-7EE177B0-2463-4BCA-84E5-14B1A2E0DE62 Q30473707-E5A8EAE7-07B0-45EA-BC90-D8050AA07073 Q30506148-1090C10D-FA52-4C0A-BD78-1D48445B3DF2 Q30981876-CBE6D74C-52A5-4C2E-B8C9-C23EA06E9A7A Q33464957-553F12F1-1AEB-43BC-861B-EC74BF29044E Q33564023-C2A4BC11-7050-4B8F-9773-937FF8C90D0A Q33604098-54FF79A8-1442-4F25-BD8F-B138483154C0 Q33655394-5120130C-C8FC-49F4-B327-D6D3E9771D33 Q33687100-66B6FB1E-2DB4-4E41-86EA-20A857F5E8A1 Q33847549-AF4B9932-6B7F-4964-92E9-9FB39F247D59 Q33865109-5FCAF406-6F1E-4A17-A7ED-25D349BC8CBE Q33889311-6353BA65-8C4F-44F9-86FC-ED154699D30C Q33993080-7484D81F-2B72-48A7-A9D2-A2F21ECFD756 Q34054143-B6E0A291-1810-4B9D-9814-F7842795773A Q34098258-343F70AF-9BE8-4234-91FE-4369D0377D27 Q34098271-71AE08E1-CEB3-47BA-BABD-733A6738AB04 Q34155467-75623817-0BFC-422F-BACA-1820FE594098

P2860

Q61386215-E024B893-72C3-4957-9DB1-01D39AC443B9

P921

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

http://www.wikidata.org/entity/Q34409573

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

@ast

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

@en

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

@nl

type

label

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

@ast

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

@en

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

@nl

prefLabel

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

@ast

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

@en

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

@nl

P1433

Q34409573-F2D96ED2-0A10-4C2B-8113-5DD9D8E10B1F

P1476

Q34409573-68569A2F-A381-4036-A8BD-A1E11A1DE26C

P2093

Q34409573-1265CDE3-23F9-4BA4-8DCD-EF3C5B64FFE2

Q34409573-17A98689-E26F-47E1-A27E-A2EDE5576AFC

Q34409573-2033C8C3-47B2-4871-AEC6-22B00E3C316B

Q34409573-3080C915-709D-47DA-B202-61C96670FAE0

Q34409573-4A5E1700-BB91-4E1F-A904-EC9499CD90E9

Q34409573-615F103F-8816-443F-8655-74EB641DD3DC

Q34409573-E93244BD-2B87-439E-A36D-93AF0D87F904

Q34409573-FD6B7340-2EFF-4400-8E1F-7E1D118EDFAE

P2507

Q34409573-2F581D0A-49B1-4233-B915-B1E3260BE8EB

P2888

Q34409573-A9B687CA-5C6E-4ABE-8579-3B3453D706B8

P304

Q34409573-2902245F-A65E-49C3-BA26-1E9EED9A79E8

P31

Q34409573-804164CF-08D9-4166-A21F-AD10582BE752

P356

Q34409573-70170202-8498-4A47-923F-8153155AB112

P407

Q34409573-F87E37F7-93FD-428B-A531-9A3E84379F7D

P433

Q34409573-B243A8FC-9A1C-4EB1-9F2E-F3E123878202

P478

Q34409573-CB8782A8-13C8-48E6-AF26-E60131F0650A

P50

Q34409573-BF91B8C9-D2C7-4110-80F9-5D3BCC8C95BD

Q34409573-D263F239-2407-4743-A1E6-178A7A68201D

P577

Q34409573-3CDFB404-F213-4CEA-8B3F-973CE6A562B3

P5875

Q34409573-4B1D3719-048E-422E-A4F7-D9CDE9FF05C0

P6179

Q34409573-479731AE-9BEF-4144-8D7F-E4EB2897B073

P698

Q34409573-31984AC3-3092-4B96-AE0C-D4DEAA9EC819

P921

Q34409573-78B3AC4B-ADC5-4C8C-AFA2-3372EFE5FCFC

Q34409573-B35C1B4B-3B4A-43FE-B191-7A8F0EEA6E4A

P356

P1433

P1476

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

@en

P2093

Andreas Zimmer

http://www.w3.org/2001/XMLSchema#string

Christian Staub

http://www.w3.org/2001/XMLSchema#string

Fabienne Burger

http://www.w3.org/2001/XMLSchema#string

François Mach

http://www.w3.org/2001/XMLSchema#string

Graziano Pelli

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Frossard

http://www.w3.org/2001/XMLSchema#string

Meliha Karsak

http://www.w3.org/2001/XMLSchema#string

Niels R Veillard

http://www.w3.org/2001/XMLSchema#string

P2507

Erratum: Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

P2888

P304

782-786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE03389

http://www.w3.org/2001/XMLSchema#string

P407

P433

7034

http://www.w3.org/2001/XMLSchema#string

P478

434

http://www.w3.org/2001/XMLSchema#string

P50

Sabine Steffens

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7920254

http://www.w3.org/2001/XMLSchema#string

P6179

1040131238

http://www.w3.org/2001/XMLSchema#string

P698

15815632

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis